arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Werewolf Therapeutics, Inc.

HOWL

$1.02 ▼ -0.07 (-6.42%) at close

27 Visible periods

22 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Werewolf Therapeutics, Inc. faces fundamental challenges with weakness in Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap $49.6M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC 34.7% ↗

FCF / Share $0.14 ↗

Trailing P/E 12.8x

Price / Book 3.0x

FCF Yield 13.4%

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

27-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-13.53M

↑ +25.2% —

FCF / Share Free cash flow per share

$0.14

↑ +162.6% —

Long-Term Debt Long-term obligations

$32.09M

— 0.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Debt to EquityDebt to Equity is concerning (bottom quartile)
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
EPS Growth YoY (%)	N/M	30.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	65.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	5.3% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-2.6% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-39.4% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-65.2% Weak → Weak Stable Year-over-year change in earnings per share Optimal: > 10%	-185.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-14.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	13.2% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	42.5% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	73.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	39.3% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	21.6% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	86.1% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	99.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	92.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	-1720.1% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	25.2% Excellent → Excellent Stable Year-over-year change in net income	25.2% Excellent ↑ Excellent Improving Year-over-year change in net income	58.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-11.7% Weak ↑ Weak Improving Year-over-year change in net income	-11.7% Weak ↑ Weak Improving Year-over-year change in net income	-11.7% Weak ↑ Weak Improving Year-over-year change in net income	-70.0% Weak ↓ Weak Declining Year-over-year change in net income	-35.1% Weak ↓ Weak Declining Year-over-year change in net income	-35.1% Weak ↓ Weak Declining Year-over-year change in net income	-35.1% Weak ↓ Weak Declining Year-over-year change in net income	-0.6% Weak ↓ Weak Declining Year-over-year change in net income	21.9% Good ↓ Good Declining Year-over-year change in net income	21.9% Good ↑ Good Improving Year-over-year change in net income	21.9% Good ↑ Good Improving Year-over-year change in net income	33.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-106.4% Weak ↑ Weak Improving Year-over-year change in net income	-106.4% Weak ↑ Weak Improving Year-over-year change in net income	-106.4% Weak → Weak Stable Year-over-year change in net income	-141.4% Weak ↓ Weak Declining Year-over-year change in net income	-94.3% Weak → Weak Stable Year-over-year change in net income	-94.3% Weak Weak Year-over-year change in net income	-94.3% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	—	48.4% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-14.1% Weak Weak Year-over-year change in free cash flow	—	—	—	-28.0% Weak Weak Year-over-year change in free cash flow	—	—	—	43.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	91.5% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-29.7% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
FCF / Net Income (x)	-0.49x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.32x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	—	1.05x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.70x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.95x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.40x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.62x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.04x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	0.91x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.99x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.30x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.13x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	34.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-23.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-20.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.0% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-8.5% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-7.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	3.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	11.3% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	15.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	15.6% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	11.0% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	29.6% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-22.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-7.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-6.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-7.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-7.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-83.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-654%)	-110.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-839%)	-33.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-325%)	-61.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-507%)	-43.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-391%)	-31.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-310%)	-27.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-285%)	-18.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-221%)	-15.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-204%)	-13.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-192%)	-10.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-172%)	-10.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-171%)	-10.1% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-167%)	-9.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-166%)	-9.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-165%)	-11.7% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-178%)	-11.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-179%)	-11.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-173%)	-11.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-178%)	-4.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-129%)	-4.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-127%)	4.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-68%)	14.3% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	12.1% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-19%)	14.9% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	13.6% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-9%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Debt to Equity (x)	—	2.63x Weak ↑ Weak Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+338%)	1.29x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+116%)	1.08x Caution ↑ Caution Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+81%)	0.77x Fair ↑ Fair Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+29%)	0.56x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-7%)	—	0.36x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-40%)	0.31x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-49%)	0.34x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-43%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	15.07x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	-9.70x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6.88x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-11.73x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-13.48x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-14.24x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-16.07x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-13.77x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-23.70x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-17.11x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-14.24x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-10.23x Weak Weak Operating income divided by interest expense Optimal: > 5x	-8.18x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-21.99M	$-14.37M	$-24.96M	$-33.63M	$-45.51M	$-59.96M	$-111.00M	$-90.74M	$-103.22M	$-99.19M	$-134.34M	$-130.06M	$-137.45M	$-147.87M	$-129.31M	$-140.45M	$-145.71M	$-143.71M	$-157.53M	$-170.44M	$-183.23M	$-84.60M	$-92.57M	—	—	—	—
Debt / EBITDA (x)	—	-2.49x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-3.56x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.09x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.83x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.83x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-1.87x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.69x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.40x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Basic EPS, GAAP (USD)	$0.08	$-0.28	$-0.16	$-0.36	$-0.40	$-0.40	$-0.46	$-0.38	$-0.40	$-0.39	$-0.33	$-0.23	$-0.14	$-0.34	$-0.38	$-0.40	$-0.53	$-0.56	$0.95	$-0.51	$-3.82	$-83.36	$-20.05	$-6.61	$2.35	$-4.58	—
Free Cash Flow per Share (USD)	$0.14	$-0.22	—	$-0.33	—	$-0.42	—	—	—	$-0.37	—	$-0.21	$-0.31	$-0.29	—	—	—	$-0.51	—	—	—	$-5.97	—	$-5.42	$-4.58	$-4.60	—
Book Value per Share (USD)	$0.34	$0.25	$0.51	$0.63	$0.91	$1.28	$1.64	$2.04	$2.38	$2.72	$2.85	$3.15	$3.34	$3.43	$3.89	$4.28	$4.59	$5.08	$5.59	$6.22	$6.69	$-87.36	$-43.80	$-34.38	$-27.06	$-33.58	—
Tangible Book Value per Share (USD)	$0.34	$0.25	$0.51	$0.63	$0.91	$1.28	$1.64	$2.04	$2.38	$2.72	$2.85	$3.15	$3.34	$3.43	$3.89	$4.28	$4.59	$5.08	$5.59	$6.22	$6.69	$-87.36	$-43.80	$-34.38	$-27.06	$-33.58	—
Basic Weighted Avg Shares (shares)	48.60M	48.60M	—	45.80M	44.98M	44.83M	—	43.70M	43.52M	41.61M	—	35.65M	35.56M	34.78M	—	29.76M	27.52M	27.39M	—	27.19M	17.75M	1.23M	—	918,000	947,000	836,000	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$15.03M	$10.21M	$22.44M	$50.57M	$65.27M	$82.79M	$97.89M	$113.37M	$127.35M	$121.07M	$118.99M	—	—	$134.84M	$116.21M	$123.79M	$123.80M	$134.41M	$149.19M	$166.63M	$178.99M	$79.46M	$87.63M	—	—	—	—
LT Debt (USD)	—	$32.09M	$32.09M	$32.09M	$32.09M	$32.09M	—	$32.09M	$32.09M	$40.00M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$16.29M	$12.20M	$24.80M	$29.61M	$41.46M	$57.31M	$73.39M	$89.38M	$104.02M	$117.59M	$111.37M	$112.44M	$118.60M	$121.07M	$122.34M	$130.95M	$129.84M	$139.32M	$152.79M	$169.30M	$181.56M	$-153.75M	$-51.86M	$-31.56M	$-25.63M	$-28.07M	$-24.30M

📋 What is driving earnings? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Depreciation Expense (USD)	$2.45M	$398.00K	$400.00K	$402.00K	—	$426.00K	$442.00K	—	—	$464.00K	$460.00K	$445.00K	$434.00K	$425.00K	$417.00K	—	—	$98.00K	$48.00K	—	—	$39.00K	$44.00K	$41.00K	$42.00K	$23.00K	—
Net Income, GAAP (USD)	$-13.53M	$-13.53M	$-8.38M	$-18.09M	$-18.09M	$-18.09M	$-20.40M	$-16.19M	$-16.19M	$-16.19M	$-12.00M	$-11.98M	$-11.98M	$-11.98M	$-11.93M	$-15.34M	$-15.34M	$-15.34M	$-17.87M	$-7.43M	$-7.43M	$-7.43M	$-7.40M	$-3.83M	$-3.83M	$-3.83M	—
Operating Cash Flow (USD)	$6.63M	$-10.60M	$-11.02M	$-15.16M	—	$-18.95M	$-14.25M	—	—	$-15.30M	$-4.58M	$-7.21M	$-10.92M	$-9.90M	$-11.87M	—	—	$-13.95M	$-12.67M	—	—	$-7.33M	$-6.01M	$-4.92M	$-4.29M	$-3.40M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 7 years · 27 quarters

Werewolf Therapeutics, Inc.

Analytical Summary

27-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare HOWL with peers